Rhenman & Partners Asset Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-120,000
| Closed | -$348K | – | 119 |
|
|
2017
Q2 | $348K | Hold |
120,000
| – | – | 0.05% | 97 |
|
|
2017
Q1 | $413K | Hold |
120,000
| – | – | 0.07% | 89 |
|
|
2016
Q4 | $209K | Hold |
120,000
| – | – | 0.04% | 104 |
|
|
2016
Q3 | $398K | Hold |
120,000
| – | – | 0.06% | 93 |
|
|
2016
Q2 | $516K | Hold |
120,000
| – | – | 0.09% | 90 |
|
|
2016
Q1 | $675K | Buy |
120,000
+1,100
| +0.9% | +$6.19K | 0.13% | 89 |
|
|
2015
Q4 | $2.05M | Hold |
118,900
| – | – | 0.31% | 86 |
|
|
2015
Q3 | $2.51M | Buy |
118,900
+40,000
| +51% | +$844K | 0.4% | 68 |
|
|
2015
Q2 | $3.91M | Sell |
78,900
-4,280
| -5% | -$212K | 0.47% | 70 |
|
|
2015
Q1 | $6.51M | Buy |
83,180
+45,680
| +122% | +$3.58M | 1.1% | 31 |
|
|
2014
Q4 | $2.27M | Sell |
37,500
-11,900
| -24% | -$721K | 0.66% | 67 |
|
|
2014
Q3 | $2.1M | Buy |
49,400
+19,380
| +65% | +$825K | 0.62% | 62 |
|
|
2014
Q2 | $1.86M | Sell |
30,020
-2,900
| -9% | -$179K | 0.55% | 65 |
|
|
2014
Q1 | $2.14M | Buy |
32,920
+7,920
| +32% | +$515K | 0.64% | 56 |
|
|
2013
Q4 | $1.41M | Buy |
+25,000
| New | +$1.41M | 0.55% | 71 |
|